Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 04/10/2026 | CALL | $242.50 | 1,466 | +622 | +73.70% |
| 09/18/2026 | CALL | $280.00 | 2,530 | +426 | +20.25% |
| 09/18/2026 | PUT | $210.00 | 3,862 | +253 | +7.01% |
| 06/18/2026 | PUT | $210.00 | 3,690 | +247 | +7.17% |
| 10/16/2026 | PUT | $210.00 | 627 | +237 | +60.77% |
| 05/15/2026 | CALL | $250.00 | 2,312 | +180 | +8.44% |
| 04/10/2026 | PUT | $235.00 | 1,310 | -29 | -2.17% |
| 04/17/2026 | PUT | $230.00 | 6,560 | -30 | -0.46% |
| 06/18/2026 | PUT | $190.00 | 1,380 | -38 | -2.68% |
| 04/17/2026 | CALL | $270.00 | 967 | -59 | -5.75% |
| 06/18/2026 | PUT | $220.00 | 2,641 | -78 | -2.87% |
| 04/10/2026 | CALL | $245.00 | 1,116 | -262 | -19.01% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.55% | 79.47M | 12.56B |
| Vanguard 500 Index Fund | 1.94% | 60.44M | 9.55B |
| Fidelity 500 Index Fund | 0.92% | 28.66M | 4.53B |
| SPDR S&P 500 ETF Trust | 0.91% | 28.31M | 4.47B |
| iShares Core S&P 500 ETF | 0.75% | 23.33M | 3.69B |
| Vanguard Index-Value Index Fund | 0.72% | 22.6M | 3.57B |
| Select Sector SPDR Fund-Health Care | 0.68% | 21.24M | 3.36B |
| Vanguard Institutional Index Fund-Institutional Index Fund | 0.59% | 18.32M | 2.9B |
| Vanguard Specialized-Dividend Appreciation Index Fund | 0.53% | 16.62M | 2.63B |
| Washington Mutual Investors Fund | 0.40% | 12.37M | 1.96B |
Stocks Rallied After President Donald Trump's Ceasefire in Iran. Here's How to Invest Now.
04/11 05:06 am
The Motley Fool
Read moreCrohn's Disease Eight-Market Drug Forecast and Market Analysis Report 2025-2026: Novel MOAs Will Provide Market Shifts Throughout the Forecast Period to 2032
04/10 04:43 am
GlobeNewswire Inc.
Read moreCould Buying This Dividend Pharma Stock Today Set You Up for Life?
04/09 08:15 pm
The Motley Fool
Read moreMicrosoft Is Now The Biggest Deadweight On S&P 500 — And Exxon Is What Nvidia Used To Be
04/07 12:17 pm
Benzinga
Read moreTrump Imposes 100% Drug Tariffs: 5 Pharma Stocks That Won’t Pay a Dime
04/06 01:20 pm
Investing.com
Read moreJEPI vs. JEPQ: Which Is the Better Buy in April?
04/04 12:30 am
The Motley Fool
Read moreThis Healthcare Stock Barely Flinches During Market Sell-Offs
04/02 06:14 am
The Motley Fool
Read moreTrump Administration Prepares 100% Tariffs On Drugmakers Without Pricing Deals: Report
04/02 04:44 am
Benzinga
Read moreSystemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight
04/01 01:00 pm
GlobeNewswire Inc.
Read moreThe Dividend King That's Raised Its Payout for 63 Consecutive Years
03/31 01:30 pm
The Motley Fool
Read moreNew SPRAVATO® (esketamine nasal spray) data support robust effectiveness and show durable effect for treatment resistant depression in a real-world setting
03/28 04:05 am
GlobeNewswire Inc.
Read moreIs Intuitive Surgical a Buy Right Now?
03/27 05:15 pm
The Motley Fool
Read moreThe Newest Big Idea From Elon Musk: Terafab
03/27 02:16 pm
The Motley Fool
Read moreCancer Drug Developer Nanobiotix Denies Any Active Takeover Process
03/25 01:02 pm
Benzinga
Read moreJohnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie
03/19 08:25 am
Benzinga
Read moreMestag Therapeutics Announces $40 Million Financing and Appoints Chief Medical Officer and Chief Development Officer in Preparation to Enter the Clinic
03/17 04:00 am
GlobeNewswire Inc.
Read moreDefensive Sectors: Are Utilities, Staples, and Health Care Signaling Trouble?
03/17 02:44 am
Investing.com
Read moreBIO-Europe Spring® 2026: Partnering Momentum Builds as Global Biopharma Leaders Set Course for Lisbon
03/16 06:00 am
GlobeNewswire Inc.
Read moreHDV vs. SCHD: Which Dividend ETF Is Best?
03/13 02:17 pm
The Motley Fool
Read moreBladder Cancer Patients Report Delayed Diagnosis and Gaps in Support
03/13 07:00 am
GlobeNewswire Inc.
Read moreThe Largest Stock Holding in the Vanguard High Dividend Yield ETF Just Delivered Blowout Earnings. Here's Why the ETF Is Crushing the S&P 500 in 2026 and Worth Buying in March.
03/13 06:35 am
The Motley Fool
Read moreFDVV vs. HDV: 2 High-Dividend ETFs With Opposite Ideas About Big Tech
03/12 05:13 pm
The Motley Fool
Read moreGrowing Your Income vs. Maximizing It Now: The Core Difference Between VIG and HDV
03/12 03:23 pm
The Motley Fool
Read moreThe Best Dividend Stocks to Buy and Hold Forever
03/12 01:30 pm
The Motley Fool
Read moreIncome-Oriented ETFs: VYM Offers Greater Diversification, While HDV Boasts a Higher Yield
03/12 01:07 pm
The Motley Fool
Read moreDemande d’autorisation de mise sur le marché de TECVAYLI®▼ (teclistamab) en monothérapie soumise à l’EMA pour le myélome multiple en rechute ou réfractaire après au moins une ligne de traitement antérieure
03/12 07:00 am
GlobeNewswire Inc.
Read moreOrthobiologics Market to Surpass USD 9 Billion by 2031 Amid Rising Osteoarthritis Cases and Advancements in Regenerative Therapies, Says Mordor Intelligence
03/12 03:45 am
GlobeNewswire Inc.
Read moreLike Dividend Income? This Groundbreaking ETF Changed the Game for Investors
03/11 12:03 pm
The Motley Fool
Read moreMy Top 3 Dividend Kings to Buy for March 2026
03/10 12:14 pm
The Motley Fool
Read more2 No-Brainer Dividend Stocks to Buy in 2026
03/08 12:27 pm
The Motley Fool
Read moreJobs Crash, War Flares: Smart Money Hides In These Stocks
03/06 05:01 pm
Benzinga
Read moreFDA Clears Johnson & Johnson's Multiple Myeloma Combo Drug After Strong Survival Results
03/06 09:53 am
Benzinga
Read moreCytokines Market Global Forecast 2026-2032: Precise Treatments, Strategic Partnerships, and Supply Chain Resilience Fueling the $95+ Billion Market
03/05 05:44 am
GlobeNewswire Inc.
Read more10 Stocks to Own as Middle East Tensions Drive Investors Toward Safety
03/04 01:47 pm
Investing.com
Read moreAbbVie Says 55% Of Crohn's Patients Reached Remission With Skyrizi, Bolsters Competitive Positioning Against Johnson & Johnson
03/02 01:28 pm
Benzinga
Read moreAntibiotics Market - 4.07% CAGR Forecast for 2026-2031 as Antimicrobial Innovation Strengthens Demand, Says Mordor Intelligence
03/02 05:59 am
GlobeNewswire Inc.
Read moreA Symbol of Crisis: As Colorectal Cancer Deaths Rise, Fight CRC Installs United in Blue on the National Mall
02/27 03:52 pm
GlobeNewswire Inc.
Read moreOne in Three Rheumatologists View BMS’ Sotyktu as a Substantial Advance in Psoriatic Arthritis Ahead of March 6 FDA Decision, According to Spherix Global Insights Data
02/27 01:31 pm
GlobeNewswire Inc.
Read moreGlobal Medical Device Cleaning Market Poised for Strong Growth as Infection Control Mandates and Reprocessing Technologies Accelerate Adoption: Verified Market Research®
02/27 11:55 am
GlobeNewswire Inc.
Read moreAdvanced Drug Delivery Market to Grow 10.2% Annually Through 2030
02/25 01:54 pm
GlobeNewswire Inc.
Read moreBoring Is Beautiful: Why Johnson & Johnson Is Beating the Tech Sector
02/25 11:17 am
Investing.com
Read more3 Vanguard ETFs to Buy That Are Crushing the S&P 500 in 2026
02/23 01:35 pm
The Motley Fool
Read moreJohnson & Johnson: This Dividend King Could Anchor a Millionaire Retirement Portfolio
02/22 02:02 pm
The Motley Fool
Read moreJ&J Eyes Mega Sale Of DePuy Synthes In Orthopedics Breakup Push
02/20 07:53 am
Benzinga
Read moreACTG Announces Publication of LATITUDE Findings in the New England Journal of Medicine
02/18 06:59 pm
GlobeNewswire Inc.
Read more